home > drugs a-z list > decavac (tetanus and diphtheria toxoids adsorbed) drug center > decavac (tetanus and diphtheria toxoids adsorbed) drug - medication guide and patient information

Prior to administration of DECAVAC (tetanus and diphtheria toxoids adsorbed) vaccine, health-care providers should inform the patient, parent, or guardian of the benefits and risks of immunization and of the importance of completing the primary immunization series or receiving recommended booster doses, as appropriate.

The health-care provider should inform the patient, parent, or guardian about the potential for adverse reactions that have been temporally associated with the administration of DECAVAC (tetanus and diphtheria toxoids adsorbed) vaccine or other vaccines containing similar ingredients. Patients, parents or guardians should be instructed to report any suspected adverse reactions to their health-care professional.

The health-care provider should provide the Vaccine Information Statements (VISs), which are required by the National Childhood Vaccine Injury Act of 1986 to be given with each immunization.

Last reviewed on RxList: 10/29/2009
This monograph has been modified to include the generic and brand name in many instances.